![Matthew Outten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Outten
Corporate Officer/Principal bei
BRIDGEBIO PHARMA, INC.
Profil
Matthew Outten is currently Chief Commercial Officer at QED Therapeutics, Inc. and Chief Commercial Officer at BridgeBio Pharma, Inc. Formerly, Mr. Outten was Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from the University of Delaware.
Aktive Positionen von Matthew Outten
| Unternehmen | Position | Beginn |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01.02.2019 |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Matthew Outten
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Matthew Outten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
